3/27
08:07 am
cgtx
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $9.00 price target on the stock.
Low
Report
Cognition Therapeutics, Inc. (NASDAQ: CGTX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $9.00 price target on the stock.
3/27
07:33 am
cgtx
Rating for CGTX
Low
Report
Rating for CGTX
3/27
07:33 am
cgtx
Rating for CGTX
Low
Report
Rating for CGTX